Aromat8-PN By XYMOGEN Overview & Drug Interactions

Check For Interactions With Aromat8-PN

Supplement: Aromat8-PN by XYMOGEN

Aromat8-PN Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Aromat8-PN by XYMOGEN

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

There were no interactions found with Aromat8-PN. This does not mean the potential for an interaction does not exist, however. There is often a lack of studies and data surrounding traditional medicine, especially concerning drug interactions, so it is important to always consult your provider before making any changes to your medication regimen.


Still looking for more information about Aromat8-PN interactions? Ask Dr. Brian Staiger about it by contacting him directly.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
1 Capsule(s)
Maximum serving Sizes:
2 Capsule(s)
Servings per container 30
UPC/BARCODE 871149004088

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Aromat8-PN Proprietary Blend
80 mg
Proprietary Blend --
Norway spruce lignan extract
0 NP
Hemlock spruce
8-Prenylnaringenin
0 NP
8-Prenylnaringenin

Other Ingredients:
Microcrystalline Cellulose
HPMC
Stearic Acid
Magnesium Stearate
Silica


Label Statments:


General Statements
- Professional Use Only
- Research suggest lignans and 8-PN can support the body's natural process of healthy aromatase activity and exert phytoestrogen (e.g., enterolactone) and antioxidant activity. This all-natural formula may support cardiovascular, bone, breast, and prostate health and help relieve normal menopausal discomforts.
- ePV: Exclusive Professional Formulas
- This package is completely recyclable Scan To Learn More!
Brand IP Statement(s)
- Not for resale on third-party websites, including, but no limited to, Amazon and eBay.
- 2015 Xymogen
Suggested/Recommended/Usage/Directions
- Directions: Take on to two capsules daily, or use as directed by your healthcare practitioner.
Precautions
- Consult your healthcare practitioner prior to use.
- Individuals taking medication should discuss potential interactions with their healthcare practitioner.
- Do not use if tamper seal is damaged.
Formula
- Aromat8-PN delivers a unique, proprietary blend of 8-prenylnaringenin (8-PN) from 8-PN from hops and plant-lignin extract at clinically relevant levels.
- Targeting estrogen activity for men and women
FDA Disclaimer Statement
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Storage
- Storage: Keep tightly closed in a cool, dry place out of reach of children.
Formulation
- Does Not Contain: Wheat, gluten, corn, soy, animal or dairy products, fish, shellfish, peanuts, tree nuts, egg, ingredients derived from genetically modified organisms (GMOs), artificial colors, artificial sweeteners, or artificial preservatives.
- Vegetarian Caps
Seals/Symbols
- Third-Party GMP Compliant Verified
- Vegetarian Caps
FDA Statement of Identity
- Dietary Supplement
General
- ZLB-8PN-04 REV. 051915

Brand Information

See all products by this brand

Manufacturer
Name XYMOGEN
Street Address 6900 Kingspointe Pkwy.
City Orlando
State FL
ZipCode 32819
Phone Number 800-647-6100
Web Address www.xymogen.com

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.